| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
|
N Engl J Med
|
2002
|
16.23
|
|
2
|
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
|
JAMA
|
2001
|
15.85
|
|
3
|
Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
|
Circulation
|
2003
|
8.29
|
|
4
|
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
|
Circulation
|
2003
|
6.99
|
|
5
|
Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.
|
Circulation
|
2002
|
2.84
|
|
6
|
C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study).
|
Am J Cardiol
|
2004
|
2.08
|
|
7
|
Hemoglobin A1c level and future cardiovascular events among women.
|
Arch Intern Med
|
2004
|
1.76
|
|
8
|
High-sensitivity C-reactive protein: clinical importance.
|
Curr Probl Cardiol
|
2004
|
1.69
|
|
9
|
Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
|
Am J Med
|
2003
|
1.62
|
|
10
|
Blood pressure, C-reactive protein, and risk of future cardiovascular events.
|
Circulation
|
2003
|
1.56
|
|
11
|
C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis.
|
J Thromb Haemost
|
2004
|
1.46
|
|
12
|
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study.
|
Lancet
|
2002
|
1.46
|
|
13
|
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction.
|
Thromb Haemost
|
2001
|
1.45
|
|
14
|
C-reactive protein is independently associated with fasting insulin in nondiabetic women.
|
Arterioscler Thromb Vasc Biol
|
2003
|
1.43
|
|
15
|
Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis.
|
Atherosclerosis
|
2002
|
1.42
|
|
16
|
Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.
|
Hum Mol Genet
|
2003
|
1.33
|
|
17
|
Prevalence and 3-year incidence of abuse among postmenopausal women.
|
Am J Public Health
|
2004
|
1.19
|
|
18
|
Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
|
Circulation
|
2004
|
0.96
|
|
19
|
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
|
Curr Atheroscler Rep
|
2003
|
0.92
|
|
20
|
Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction.
|
Atherosclerosis
|
2004
|
0.88
|
|
21
|
Prospective evaluation of the alcohol dehydrogenase gamma1/gamma2 gene polymorphism and risk of stroke.
|
Stroke
|
2004
|
0.80
|
|
22
|
A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke.
|
Stroke
|
2002
|
0.79
|